OPM’s annual guidance to FEHB carriers calls for cost-cutting measures, including ending cash incentives tied to childhood vaccine adoption. The letter also urges insurers to require therapy or other steps before covering GLP-1 drugs for obesity, signaling potential future changes in FEHB plan coverage and utilization rules.
Read full story at GovExec — Pay & Benefits →Related Topics
fehbopmhealth-insurance-carriersglp-1obesity-treatmentvaccine-policyplan-year-guidance